Degrading AR-Dependent Cancers: Expanding the Role of PROTACs

Affiliations

• ¹ Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, United States.
• ² Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States. Electronic address: cspeers@med.umich.edu.